CN107412181B - 一种两亲性白芨胶骨架控制脂质纳米粒释放的制备方法 - Google Patents
一种两亲性白芨胶骨架控制脂质纳米粒释放的制备方法 Download PDFInfo
- Publication number
- CN107412181B CN107412181B CN201710541292.3A CN201710541292A CN107412181B CN 107412181 B CN107412181 B CN 107412181B CN 201710541292 A CN201710541292 A CN 201710541292A CN 107412181 B CN107412181 B CN 107412181B
- Authority
- CN
- China
- Prior art keywords
- bletilla striata
- skeleton
- release
- preparation
- cholesterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001313857 Bletilla striata Species 0.000 title claims abstract description 43
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 150000002632 lipids Chemical class 0.000 title claims abstract description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 46
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 46
- 239000005017 polysaccharide Substances 0.000 claims abstract description 46
- 150000004676 glycans Chemical class 0.000 claims abstract description 37
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 30
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims abstract description 28
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims abstract description 28
- 229960004245 silymarin Drugs 0.000 claims abstract description 28
- 235000017700 silymarin Nutrition 0.000 claims abstract description 28
- 238000005260 corrosion Methods 0.000 claims abstract description 11
- 230000007797 corrosion Effects 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000011068 loading method Methods 0.000 claims abstract description 8
- 238000004108 freeze drying Methods 0.000 claims abstract description 6
- 238000000265 homogenisation Methods 0.000 claims abstract description 6
- 238000002844 melting Methods 0.000 claims abstract description 6
- 230000008018 melting Effects 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000003825 pressing Methods 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 239000002244 precipitate Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 22
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- 238000000967 suction filtration Methods 0.000 claims description 9
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 150000003904 phospholipids Chemical class 0.000 claims description 8
- 241001313855 Bletilla Species 0.000 claims description 7
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 5
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000005642 Oleic acid Substances 0.000 claims description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000013563 matrix tablet Substances 0.000 claims description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 150000003222 pyridines Chemical class 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 229940014800 succinic anhydride Drugs 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 4
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 claims description 4
- OVIISSOUXFJLSM-KPNWGBFJSA-N butanedioic acid;(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol Chemical compound OC(=O)CCC(O)=O.C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 OVIISSOUXFJLSM-KPNWGBFJSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 229920001993 poloxamer 188 Polymers 0.000 claims description 4
- 229940044519 poloxamer 188 Drugs 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims description 3
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 3
- 239000002502 liposome Substances 0.000 claims description 2
- 230000003628 erosive effect Effects 0.000 abstract description 10
- 230000003204 osmotic effect Effects 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 3
- 239000012876 carrier material Substances 0.000 abstract description 2
- 101150101199 CHSB gene Proteins 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- -1 polysaccharide succinate polysaccharide Chemical class 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 150000004804 polysaccharides Polymers 0.000 description 4
- 108010019160 Pancreatin Proteins 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000004130 lipolysis Effects 0.000 description 3
- 229940055695 pancreatin Drugs 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- FPFSGDXIBUDDKZ-UHFFFAOYSA-N 3-decyl-2-hydroxycyclopent-2-en-1-one Chemical compound CCCCCCCCCCC1=C(O)C(=O)CC1 FPFSGDXIBUDDKZ-UHFFFAOYSA-N 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 244000272459 Silybum marianum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000002047 solid lipid nanoparticle Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Sustainable Development (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710541292.3A CN107412181B (zh) | 2017-07-05 | 2017-07-05 | 一种两亲性白芨胶骨架控制脂质纳米粒释放的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710541292.3A CN107412181B (zh) | 2017-07-05 | 2017-07-05 | 一种两亲性白芨胶骨架控制脂质纳米粒释放的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107412181A CN107412181A (zh) | 2017-12-01 |
CN107412181B true CN107412181B (zh) | 2020-04-17 |
Family
ID=60426275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710541292.3A Expired - Fee Related CN107412181B (zh) | 2017-07-05 | 2017-07-05 | 一种两亲性白芨胶骨架控制脂质纳米粒释放的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107412181B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11865211B2 (en) * | 2018-06-01 | 2024-01-09 | Insbiopharm Co., Ltd. | Nanoparticle complex showing improved cellular uptake through surface modification using lipid and manufacturing method therefor |
CN115006290A (zh) * | 2022-06-15 | 2022-09-06 | 广州品赫化妆品有限公司 | 一种植物复方精油纳米乳及其制备方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104434791A (zh) * | 2014-10-24 | 2015-03-25 | 宁夏医科大学 | 一种改性白芨多糖衍生物纳米载体的制备及应用 |
-
2017
- 2017-07-05 CN CN201710541292.3A patent/CN107412181B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104434791A (zh) * | 2014-10-24 | 2015-03-25 | 宁夏医科大学 | 一种改性白芨多糖衍生物纳米载体的制备及应用 |
Non-Patent Citations (2)
Title |
---|
《Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin》;Mingzhu Shangguan等;《Journal of Biomaterials Applications》;20141231;第28卷(第6期);摘要 * |
《胆甾醇琥珀酰基白芨多糖的制备及其理化性质研究》;毕亚静等;《药学实践杂志》;20130525;第31卷(第3期);220页2.1,左栏第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN107412181A (zh) | 2017-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Solubility and bioavailability enhancement of oridonin: a review | |
CN102228430B (zh) | 水飞蓟宾磷脂复合物的纳米混悬剂及其制备方法 | |
CN102125547A (zh) | 一种含藤黄酸类药物的药物组合物及其制备方法 | |
CN107412181B (zh) | 一种两亲性白芨胶骨架控制脂质纳米粒释放的制备方法 | |
Gong et al. | Drug-interactive mPEG-b-PLA-Phe (Boc) micelles enhance the tolerance and anti-tumor efficacy of docetaxel | |
Moghaddam et al. | Fabrication of carboxymethyl chitosan nanoparticles to deliver paclitaxel for melanoma treatment | |
Wu et al. | Amorphous silibinin nanoparticles loaded into porous starch to enhance remarkably its solubility and bioavailability in vivo | |
CN107638388B (zh) | 一种积雪草酸壳聚糖去氧胆酸嫁接物胶束及制备方法 | |
CN111407745A (zh) | 一种黄芪甲苷纳米缓释微球的制备方法 | |
Cunningham et al. | Polymers made of bile acids: From soft to hard biomaterials | |
CN114099438A (zh) | 山萘酚脂质体凝胶及其制备方法 | |
CN103655484A (zh) | 一种利用自组装技术制备紫杉醇缓释微球的方法及其产品 | |
CN109481403A (zh) | 一种壳聚糖修饰的醋酸曲安奈德脂质体及制备方法 | |
CN105796529B (zh) | 一种藤黄酸自组装聚合物纳米粒的制备方法及其应用 | |
CN108635338B (zh) | 一种外用雷公藤甲素脂质纳米粒及制备方法 | |
CN104127386A (zh) | 一种大叶茜草素/壳聚糖纳米微球及其制备方法和应用 | |
CN102008454B (zh) | 包载黄豆苷元的plga纳米颗粒及其制备方法 | |
CN107019682A (zh) | 一种尼莫地平脂质纳米粒及其制备工艺 | |
CN103393606B (zh) | 一种野生仙人掌多糖明胶微球及其制备方法 | |
Wang et al. | Casein nanoparticles as oral delivery carriers for improved bioavailability and hypoglycemic activity of apigenin. | |
CN103040791B (zh) | 一种可促口服吸收的积雪草酸脂质纳米粒及其制备方法 | |
CN100544738C (zh) | 一种抗肿瘤的中药制剂 | |
CN112121028B (zh) | 一种辛伐他汀固体纳米粒制剂及其制备方法 | |
Gupta et al. | Biodegradable microparticulate drug delivery system of diltiazem HCl | |
CN106361727A (zh) | 银杏内酯‑pva纳米粒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200325 Address after: 1688 No. 330004 Jiangxi city of Nanchang province Wanli District Meiling Road Applicant after: JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE Address before: 330004 School of life sciences, Jiangxi University of traditional Chinese medicine, 1688 Meiling Avenue, Wanli District, Nanchang City, Jiangxi Province Applicant before: Zhang Qi |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211020 Address after: 330115 floors 1-3, building 1, xinqizhou public R & D center, innovation city of traditional Chinese medicine, Ganjiang new area, Nanchang City, Jiangxi Province Patentee after: Ganjiang New Area Zhiyao Shanhe Technology Co.,Ltd. Address before: No. 1688 Meiling Avenue, Wanli District, Nanchang City, Jiangxi Province Patentee before: JIANGXI University OF TRADITIONAL CHINESE MEDICINE |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211103 Address after: 330004 Room 202, 2nd floor, Jiangxi University of traditional Chinese medicine, Wanli District, Nanchang City, Jiangxi Province (No. 818 Meiling Avenue) Patentee after: Jiangxi Xianren bencaotang Biotechnology Co.,Ltd. Address before: 330115 floors 1-3, building 1, xinqizhou public R & D center, innovation city of traditional Chinese medicine, Ganjiang new area, Nanchang City, Jiangxi Province Patentee before: Ganjiang New Area Zhiyao Shanhe Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200417 |
|
CF01 | Termination of patent right due to non-payment of annual fee |